Cardiac Science to Present at the UBS Global Life Sciences ... ( BOTHELL Wash. Sept. 17 /- Cardiac...)

Cardiac Science to Present at the UBS Global Life Sciences Conference

Date:9/17/2007

BOTHELL, Wash., Sept. 17 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in advanced cardiac monitoring and defibrillation products, announced today that it will present at the UBS Global Life Sciences Conference at the Grand Hyatt in New York City. The Company's presentation is scheduled for Monday, September 24, 2007 at 3:30 p.m.

Eastern Time. Michael Matysik, senior vice president and chief financial officer, will review the Company's business strategy and recent financial results.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO)

Attendance at the conference is by invitation only. Cardiac Science will offer a live audio webcast of its presentation, which may be accessed at the Company's website at http://www.cardiacscience.com. An archived replay of the presentation will also be available following the live presentation and can be accessed at http://www.cardiacscience.com.

About Cardiac Science Corporation

Cardiac Science is truly at the heart of saving lives. The Company develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor - defibrillators and cardiology data management systems. Cardiac Science also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maint
'/>"/>

SOURCE Cardiac Science Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Gene HPA-2 Met linked to cardiac arrest
3. Defibrillators In Public Places Will Help Cardiac Patients
4. Supplement helps cardiac surgery
5. Cardiac diseases develop early
6. Latest device for cardiac revival under test
7. Bone marrow stem cells may help repair cardiac tissues
8. Heart problems detected better with a Cardiac MRI
9. Cardiac events better treated with intense cholesterol-lowering regime
10. Sudden Cardiac Death due to inherited Heart Disease
11. Vasopressin Found To Boost Survival In Sudden Cardiac arrest

Post Your Comments:

(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...

(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...

(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...

(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...

Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2 Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2 Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2 Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2

[0] U-M to house leading drug database [0] Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course [0] Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region [0] Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer

...g their appointments with their doctors and practi...ted by Developing //Patient Partnerships. The poll...he doctors were not kept while 5 million practice ...ast year. The problem is more prevalent in London ...

...sue of the Journal, Vascular Surgery, researchers ...ve found //that certain risks factors put people y...l vascular disease (PVD). The findings were based...ple younger than 60 and a similar number of people...

...dical Center scientists have discovered that alter...d clues to the reasons why// certain people are vu...TA2 and the army of genes it manipulates may actua...rtery disease. This finding may also show the way ...

...erved that public health and prevention often get ...funding. This is probably// because the significan... saved through expensive, high-tech medical care i...urces could help several more people through preve...

Other Medicine News:Health News:Gene variants hold clues about vulnerability to cardiovascular disease 2 Health News:Gene variants hold clues about vulnerability to cardiovascular disease 3 Health News:Gene variants hold clues about vulnerability to cardiovascular disease 4 Health News:Lives Saved through Simple Changes 2

Patients Miss Appointments...Regularly People Under 60 At Risk Of Premature Peripheral Vascular Disease Gene variants hold clues about vulnerability to cardiovascular disease Lives Saved through Simple Changes

(Date:10/8/2008)...s Research That May Offer New Hope to,Heart Failur...nally, over 3,000 people are,waiting for a heart t...alf,of those will receive a transplant. Now, pione... paving the way for how to treat congestive heart,...ews Release, go to:, http://www.prnewswire.com/mnr...

(Date:10/8/2008)...e TAXUS(R) Element(TM) Platinum Chromium ... 8 /- Boston Scientific,Cor... completed enrollment in,the PERSEUS trial, design...S(R) Element(TM) paclitaxel-eluting coronary stent... 1,500 patients at 100 U.S. and,international cent...

(Date:10/8/2008)...ical improvement in patients with pulmonary a...t options have limited benefit for this debilitati...essel disease, -- Imatinib mesylate, available ...s, known to inhibit protein associated with PAH, ...inib mesylate in PAH in 2009 EAST HANOVER, N...

(Date:10/7/2008)... device for detecting polyps that can be ...Fla., Oct. 7 /- At the American Colle...n Orlando (ACG 2008), renowned,gastroenterologist ...institutional clinical study that evaluated the ef...vice that is designed to improve the ability,of ph...

[0] Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit [0] Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent [0] Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease [0] National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon

...eady being treated with maximally,tolerated lipid-...ons in LDL-C with similar reductions in other athe... NEW ORLEANS, and CARLSBAD, Calif., March 26, 2007...nc. announced,results from its ongoing Phase 2 cli...gous familial hypercholesterolemia (HoFH),present...

... 2007 /PRNewswire-FirstCall/ --,Alfacell Corporati...nstrating the potential of ONCONASE (ranpirnase) f...CLC) were recently,published in Anticancer Researc...ae Lee, Ph.D., at the University of,Pennsylvania, ...xic,RNase, Ranpirnase, on A549 Human Lung Cancer X...

Other Medicine Technology:Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 2 Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 3 Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 4 Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 5 Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 6 In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 2 In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 3

Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research

Last 3-6 months average refrigeration will prolong life. Pupil gauge printed on penlight 4 1/2" long 1/2" around.

Maxi-Lite diagnostic penlight features a twist-on backswitch.

Heavy duty, all purpose illuminator available in blue and green. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentra

Heavy duty, all purpose illuminator available in black only. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentrated l

Medicine Products:

Disposable Medical Penlight Maxi-Lite Diagnostic Penlight Mini 1000 Cliplamp with Handle Mini 2000 Cliplamp with Handle

Cardiac Science to Present at the UBS Global Life Sciences ...( BOTHELL Wash. Sept. 17 /- Cardiac...),Health